Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers

This study has been completed.
Sponsor:
Information provided by:
Stanford University
ClinicalTrials.gov Identifier:
NCT00185913
First received: September 12, 2005
Last updated: April 20, 2010
Last verified: April 2010
  Purpose

The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.


Condition
Lung Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers

Resource links provided by NLM:


Further study details as provided by Stanford University:

Biospecimen Retention:   Samples With DNA

blood


Estimated Enrollment: 50
Study Start Date: September 2000
Study Completion Date: May 2008
Primary Completion Date: October 2003 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Newly diagnosed patients with lung cancer who are undergoing surgical resection of their tumors

Criteria

Inclusion Criteria:- Newly diagnosed patients with lung cancer who are undergoing surgical resection of their tumors

Exclusion Criteria:- Patients without non-small cell lung cancer

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00185913

Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Quynh-Thu Le Stanford University
  More Information

No publications provided

Responsible Party: Quynh-Thu Le, Stanford University School of Medicine
ClinicalTrials.gov Identifier: NCT00185913     History of Changes
Other Study ID Numbers: LUN0006, 75318, LUN0006
Study First Received: September 12, 2005
Last Updated: April 20, 2010
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Carcinoma, Non-Small-Cell Lung
Lung Neoplasms
Carcinoma, Bronchogenic
Bronchial Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on September 16, 2014